Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0218 per EA under NDC 29300024405. Its NADAC has been published 347 times since Mar 25, 2020.

FDA first approved this application on Nov 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 5 MG TABLET

Buspirone Hydrochloride
$0.0218per EA

Strength

5 mg/1

NDC

29300024405

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210907

FDA Approved

11/14/2019

TE Code

AB

On Market Since

11/14/2019

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 347 times since Mar 25, 2020, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0218 per EA
All-time high$0.0323 (Apr 15, 2020)
All-time low$0.0174 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0216
Median price$0.0261
Average price$0.0257
Largest weekly change-25.2% (Nov 20, 2024)
Weeks tracked347
Tracking sinceMar 25, 2020

Price History

1W

0.0%

1M

-0.5%

3M

+0.9%

6M

-0.7%

1Y

+2.0%

3Y

-12.5%

5Y

-19.4%

All

-32.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0218 per EA (NDC 29300024405), effective Nov 11, 2026.

How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 32.3%. It has been tracked across 347 weekly CMS publications since Mar 25, 2020.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?

Since Mar 25, 2020, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0323 (Apr 15, 2020), with a median of $0.0261 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 5 MG TABLET, is $0.0217 per EA — about 0% below BUSPIRONE HCL 5 MG TABLET.

Who manufactures BUSPIRONE HCL 5 MG TABLET?

BUSPIRONE HCL 5 MG TABLET (NDC 29300024405) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.